Nishida Y, Kamatani N, Miyamoto T
J Pharm Pharmacol. 1984 May;36(5):354-5. doi: 10.1111/j.2042-7158.1984.tb04396.x.
Liposomal-entrapped methoxypolyethyleneglycol (PEG) modified uricase was used to study the plasma urate lowering effect after its oral administration to chickens. Plasma uric acid concentrations fell gradually and were accompanied by a rise in plasma uricolytic activity. Serum from chickens given PEG-modified uricase liposomes did not react with native uricase in immunodiffusion plates. These results suggested the clinical usefulness of liposome-entrapped PEG modified uricase in the treatment of hyperuricaemia.
脂质体包裹的甲氧基聚乙二醇(PEG)修饰尿酸酶被用于研究其对鸡口服给药后的血浆尿酸降低效果。血浆尿酸浓度逐渐下降,并伴有血浆尿酸分解活性的升高。给予PEG修饰尿酸酶脂质体的鸡的血清在免疫扩散板中不与天然尿酸酶发生反应。这些结果表明脂质体包裹的PEG修饰尿酸酶在治疗高尿酸血症方面具有临床应用价值。